MedTrace Logo

Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC

NCT05969418 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-05-22

No results posted yet for this study

Summary

To evaluate the activity of neovascular macula degeneretion as assessed by SD-OCTand OCT-A using a split-person study design and deep-learning quantification.

Conditions

  • Macular Degeneration Choroidal Neovascularization

Interventions

DIAGNOSTIC_TEST

Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter

Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter before and after ANTI-VEGF treatment

Sponsors & Collaborators

  • Federico II University

    lead OTHER

Principal Investigators

  • Ciro Costagliola, MD · Federico II University

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2023-07-20
Completion
2023-12-21

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05969418 on ClinicalTrials.gov